Ultivue

About:

Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.

Website: http://www.ultivue.com

Twitter/X: Ultivue

Top Investors: Northpond Ventures, ARCH Venture Partners, Ally Bridge Group, Tao Capital Partners, Yonghua Capital

Description:

Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing. Ultivue produces reagents that enable researchers to obtain microscopic images at an unprecedented resolution that helps to understand of biology and medicine. Ultivue's products are designed for fluorescent microscopy-based research and will eventually be valuable for clinical diagnostic use.

Total Funding Amount:

$111M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2015-01-01

Contact Email:

contact(AT)ultivue.com

Founders:

David R. Walt, Peng Yin, Ralf Jungmann

Number of Employees:

51-100

Last Funding Date:

2024-07-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai